Clevidipine in Acute Heart Failure: Results of the PRONTO Study -

Clevidipine in Acute Heart Failure: Results of the PRONTO Study
Information type: Randomised controlled trials
Source: American Heart Journal
Specialities: Cardiovascular system disorders
Summary
This RCT in 104 patients with hypertensive acute heart failure reported that more patients (71%) on clevidipine reached sBP within pre-specified target BP range (TBPR) than standard of care IV anti-hypertensive therapy (37%), p=0.002 and clevidipine was faster to TBPR, p=0.0006.
UKMi comment
Clevidipine (Cleviprex) is a rapidly acting, arterial selective intravenous calcium channel blocker licensed for the rapid reduction of blood pressure in the perioperative setting; and is expected to be launched in the UK in 2014.
Related links: